Neonatal Seizures

Neonatal seizures are the most common overt sign of neurological dysfunction in the newborn and usually point to an identifiable underlying cause rather than a primary epilepsy. Their recognition is complicated by frequently subtle clinical features and by a poor correspondence between visible movements and electrical seizure activity, which is why electroencephalographic monitoring has become central to their definition.

Definition

A neonatal seizure is a paroxysmal alteration in neurological function, electrographically a sudden abnormal and self-limited rhythmic discharge, occurring in the first weeks of life, most often as a symptom of an acute brain insult or a specific etiology rather than as established epilepsy.

Scope

This entry covers what defines a seizure in the neonatal period, the major underlying causes, the gap between clinical and electrographic seizures, the place of electroencephalographic and amplitude-integrated electroencephalographic monitoring, and the contemporary classification framework. It treats neonatal seizures as a reference topic and provides no drug dosing or individualized treatment guidance.

Core questions

• What underlying conditions most often cause neonatal seizures?
• Why do clinical and electrographic seizures often diverge in the newborn?
• What is the role of EEG and amplitude-integrated EEG?
• How are neonatal seizures classified in current frameworks?

Key concepts

• Acute symptomatic seizures
• Electroclinical dissociation (subclinical seizures)
• Electrographic seizure
• Continuous EEG and amplitude-integrated EEG (aEEG)
• Hypoxic-ischemic encephalopathy as a leading cause
• Neonatal-onset epilepsy and genetic etiologies
• ILAE neonatal seizure classification

Mechanisms

Most neonatal seizures are acute symptomatic events provoked by an underlying insult, the commonest being hypoxic-ischemic encephalopathy, with stroke, intracranial hemorrhage, infection, and metabolic disturbances among other causes; a minority reflect genetic or structural neonatal-onset epilepsies. The immature brain has a distinctive balance of excitation and inhibition that shapes how seizures are generated and expressed and that contributes to electroclinical dissociation, in which electrographic seizures occur without clear clinical signs or clinical events occur without an electrographic correlate. This dissociation, described in the classification and monitoring literature, underlies the emphasis on electroencephalographic confirmation (Pressler 2021).

Clinical relevance

Because seizures usually signal a treatable or prognostically important underlying condition, their detection prompts a search for the cause and informs outcome assessment; the frequent subtlety of clinical signs is the rationale for electroencephalographic monitoring in at-risk infants. This material describes the condition, its causes, and its evaluation framework; it does not provide medication choices, dosing, or individualized management.

Epidemiology

Seizures are more frequent in the neonatal period than at any other time of life, and they occur disproportionately in preterm infants and in those with acute brain injury such as hypoxic-ischemic encephalopathy or stroke. A substantial proportion of electrographic seizures in monitored high-risk infants have no clinical correlate, which means clinical observation alone underestimates seizure burden (van Rooij 2010; Pressler 2021).

Evidence & guidelines

A randomized trial comparing first-line agents framed the limited efficacy of monotherapy in controlling neonatal seizures (Painter 1999), and a trial of treating electrographically detected subclinical seizures examined the value of monitoring-guided care (van Rooij 2010). The International League Against Epilepsy issued a dedicated classification for neonatal seizures emphasizing electrographic confirmation (Pressler 2021), and reviews describe the genetic neonatal-onset epilepsies (McTague 2016).

History

Neonatal seizures were long classified by their clinical appearance into subtle, clonic, tonic, and myoclonic types, but the recognition that many electrographic seizures lack clinical signs, and that some clinical events lack an electrographic correlate, shifted the field toward electroencephalography-based definition. The advent of continuous and amplitude-integrated electroencephalography, the growing understanding of genetic neonatal-onset epilepsies, and a dedicated International League Against Epilepsy classification reshaped how the condition is defined and studied.

Debates

Should treatment target electrographic as well as clinical seizures?

Because many seizures are subclinical, whether and how aggressively to treat electrographically detected events that lack clinical signs, and how this affects outcome, remains debated and was the focus of dedicated trial work.

Key figures

• Joseph J. Volpe
• Ronit M. Pressler
• Eli M. Mizrahi

Seminal works

• painter-1999
• pressler-2021

Frequently asked questions

Are neonatal seizures the same as epilepsy?

Usually not. Most neonatal seizures are acute symptomatic events caused by an underlying insult such as hypoxic-ischemic injury, stroke, infection, or metabolic disturbance, rather than the recurrent unprovoked seizures that define epilepsy; a smaller group reflects genetic or structural neonatal-onset epilepsies.

Why is EEG important for diagnosing neonatal seizures?

Many electrographic seizures in newborns produce few or no visible signs, and some clinical movements are not seizures, so electroencephalographic monitoring is used to confirm seizures and to gauge their true burden.